BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 21394427)

  • 1. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.
    Kherbeck N; Tamby MC; Bussone G; Dib H; Perros F; Humbert M; Mouthon L
    Clin Rev Allergy Immunol; 2013 Feb; 44(1):31-8. PubMed ID: 21394427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.
    Wang RR; Yuan TY; Wang JM; Chen YC; Zhao JL; Li MT; Fang LH; Du GH
    Pharmacol Res; 2022 Jun; 180():106238. PubMed ID: 35504356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cells and autoantibodies in pulmonary arterial hypertension.
    Li C; Liu P; Song R; Zhang Y; Lei S; Wu S
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1047-1057. PubMed ID: 29036539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in pulmonary arterial hypertension.
    Dorfmüller P; Perros F; Balabanian K; Humbert M
    Eur Respir J; 2003 Aug; 22(2):358-63. PubMed ID: 12952274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.
    Blum LK; Cao RRL; Sweatt AJ; Bill M; Lahey LJ; Hsi AC; Lee CS; Kongpachith S; Ju CH; Mao R; Wong HH; Nicolls MR; Zamanian RT; Robinson WH
    Eur J Immunol; 2018 May; 48(5):874-884. PubMed ID: 29369345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
    Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, growth factors, and pulmonary vascular remodeling.
    Hassoun PM; Mouthon L; Barberà JA; Eddahibi S; Flores SC; Grimminger F; Jones PL; Maitland ML; Michelakis ED; Morrell NW; Newman JH; Rabinovitch M; Schermuly R; Stenmark KR; Voelkel NF; Yuan JX; Humbert M
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S10-S19. PubMed ID: 19555853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.
    El Chami H; Hassoun PM
    Compr Physiol; 2011 Oct; 1(4):1929-41. PubMed ID: 23733693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
    Rabinovitch M; Guignabert C; Humbert M; Nicolls MR
    Circ Res; 2014 Jun; 115(1):165-75. PubMed ID: 24951765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of immune system and autoimmunity in pulmonary arterial hypertension: A review.
    Han Z; Li X; Cui X; Yuan H; Wang H
    Pulm Pharmacol Ther; 2022 Feb; 72():102094. PubMed ID: 34740751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and opportunities in treating inflammation associated with pulmonary hypertension.
    Voelkel NF; Tamosiuniene R; Nicolls MR
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):939-51. PubMed ID: 27096622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies.
    Colvin KL; Cripe PJ; Ivy DD; Stenmark KR; Yeager ME
    Am J Respir Crit Care Med; 2013 Nov; 188(9):1126-36. PubMed ID: 24093638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
    Liang S; Desai AA; Black SM; Tang H
    Adv Exp Med Biol; 2021; 1303():275-303. PubMed ID: 33788198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
    Jones RJ; De Bie EMDD; Groves E; Zalewska KI; Swietlik EM; Treacy CM; Martin JM; Polwarth G; Li W; Guo J; Baxendale HE; Coleman S; Savinykh N; Coghlan JG; Corris PA; Howard LS; Johnson MK; Church C; Kiely DG; Lawrie A; Lordan JL; Mackenzie Ross RV; Pepke Zaba J; Wilkins MR; Wort SJ; Fiorillo E; Orrù V; Cucca F; Rhodes CJ; Gräf S; Morrell NW; McKinney EF; Wallace C; Toshner M;
    Am J Respir Crit Care Med; 2022 Jul; 206(1):81-93. PubMed ID: 35316153
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammation in pulmonary arterial hypertension.
    Price LC; Wort SJ; Perros F; Dorfmüller P; Huertas A; Montani D; Cohen-Kaminsky S; Humbert M
    Chest; 2012 Jan; 141(1):210-221. PubMed ID: 22215829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation.
    Brun H; Holmstrøm H; Thaulow E; Damås JK; Yndestad A; Aukrust P; Ueland T
    Congenit Heart Dis; 2009; 4(3):153-9. PubMed ID: 19489942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first.
    Cohen-Kaminsky S; Hautefort A; Price L; Humbert M; Perros F
    Drug Discov Today; 2014 Aug; 19(8):1251-6. PubMed ID: 24747559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.